• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Vital Images booms

Article

Medical software developer Vital Images achieved a 59% increase in second quarter 2003 revenues and triple the net income of the year-ago quarter. Revenues in Q2 rose to $7.5 million from $4.9 million. Core revenue components-software license fees and

Medical software developer Vital Images achieved a 59% increase in second quarter 2003 revenues and triple the net income of the year-ago quarter. Revenues in Q2 rose to $7.5 million from $4.9 million. Core revenue components-software license fees and maintenance and services-jumped to $6.7 million from $4.2 million. For the second quarter of 2003, the company reported net income of $666,000. Sales to Toshiba accounted for 35% of the company's second quarter revenue, or $2.6 million, compared with $1.4 million in the previous period. Company executives have boosted their 2003 guidance to predict between 45% and 50% growth in core revenue components, with earnings of $2.7 million to $3.1 million. They anticipate positive cash flow for the year.

Related Videos
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Related Content
© 2024 MJH Life Sciences

All rights reserved.